Biotech stocks rally on drug innovation and M&A
Moderna gave investors a scare as its stock plunged on Thursday. But it’s still one of the hottest…
Next week brings major risks for the stock market, just as the AI trade keeps faltering
Next week will bring major risks for a stock market that’s trying to find its footing as the…
AstraZeneca CEO says Summit drug could drive future cancer combos
AstraZeneca CEO Pascal Soriot told CNBC on Monday that Summit Therapeutics‘ lead drug could help power next-generation cancer…
One drug, many rare diseases
Ron Nickel | Design Pics | Getty Images CNBC Advisory Board member Dr. Anna Greka has built her…
Stocks making the biggest moves midday: CCL, FICO, BE, IOVA
Here are some of the companies making headlines in midday trading. Carnival — Carnival’s stock rose 12% after…
Rare disease is taking his sight. Access to a treatment is hard to get
Judy and Courtney Stecker with their sons, Read (left) and Wheeler (right). Judy and Courtney Stecker CNBC Cures…
BioCryst is profitable. Now it wants to buy more rare disease drugs
CNBC Cures is proudly underwritten by Alexion, AstraZeneca Rare Disease, whose support enables our journalism to elevate stories…
FDA approves Gilead HIV pill Bixlenvo designed to simplify treatment
Gilead Bixlenvo drug Courtesy: Gilead The Food and Drug Administration approved a once-daily HIV pill from Gilead that…
The startup using AI to help build custom treatments for rare diseases
Jacalyn Lee, founder of The DAND Alliance, and her youngest daughter Isla. Jacalyn Lee CNBC Cures is proudly…
Court rules companies can’t import Gilead medications from overseas
Nikos Pekiaridis | Nurphoto | Getty Images A court ruling this week in favor of Gilead Sciences could…
Morgan Stanley says buy these quality stocks. They also pay dividends
As the market broadens out, investors should seek quality stocks, according to Morgan Stanley. On Tuesday , the…
Stocks making the biggest moves premarket: AZN, PEP, CRM, LEVI
Check out the companies making the biggest moves in premarket trading: AstraZeneca — The biopharmaceutical company tumbled 8%…